Skip to main content
High RiskFDAfda-F-0139-2014OTHER

WELLTRIENTS DIGESTAIDS FORMULA #2, 90 capsules per bottle. Item #61256-90

Units Affected
935
Recall Date
October 2, 2013
Issuing Agency
Hazard
Other

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0139-2014.

Creation's Garden Natural Products (CGNP) is recalling Welltrients Digestaids Formula #2 because it has been found to contain chloramphenicol.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0139-2014.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Creation's Garden Natural Products Inc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0139-2014.

Creation's Garden Natural Products Inc

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Creation's Garden Natural Products Inc Recall FAQ

Creation's Garden Natural Products Inc is the subject of a baby food & formula safety report: WELLTRIENTS DIGESTAIDS FORMULA #2, 90 capsules per bottle. Item #61256-90. The notice was published on October 2, 2013 by the U.S. Food and Drug Administration (FDA). Approximately 935 units are potentially affected.